Scientific and Medical Equipment House Company
4014.SRSAUHealthcare● Active
$31.50
$-0.10(-0.32%)
Market Cap$945000000
P/E Ratio—
52W High$41
52W Low$26
Scientific and Medical Equipment House Company (4014.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4014.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.88B | $0.88B | $0.80B | $0.71B | $0.70B |
| Cost of Revenue | $0.75B | $0.84B | $0.67B | $0.56B | $0.55B |
| Gross Profit | $0.12B | $0.04B | $0.13B | $0.15B | $0.15B |
| Gross Margin %(computed) | 13.93% | 4.48% | 16.65% | 21.69% | 21.87% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.02B | $0.02B | $0.02B | $0.07B | $0.05B |
| Total Operating Expenses | $0.08B | $0.07B | $0.06B | $0.12B | $0.07B |
| Operating Income | $0.04B | $0.04B | $0.07B | $0.05B | $0.10B |
| Operating Margin %(computed) | 4.59% | 4.48% | 8.59% | 7.10% | 14.13% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.02B | $0.00B |
| Interest Expense | $0.02B | $0.03B | $0.03B | $0.02B | $0.01B |
| Income Before Tax | $0.04B | $0.04B | $0.05B | $0.03B | $0.08B |
| Income Tax Expense | $0.01B | $0.01B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.03B | $0.02B | $0.04B | $0.02B | $0.08B |
| Net Margin %(computed) | 3.24% | 2.81% | 5.01% | 2.46% | 11.08% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.95 | $0.87 | $1.34 | $0.59 | $2.58 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.02B |
| EBITDA | $0.06B | $0.05B | $0.10B | $0.06B | $0.11B |
| EBITDA Margin %(computed) | 6.57% | 5.75% | 12.61% | 8.54% | 15.96% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Scientific and Medical Equipment House Company data
About Scientific and Medical Equipment House Company (4014.SR) Income Statement
Scientific and Medical Equipment House Company (4014.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 4014.SR reported revenue of $0.88B, gross profit of $0.12B (gross margin 13.93%), and net income of $0.03B — a net profit margin of 3.24%.
Frequently asked questions
4014.SR · 4 questionsScientific and Medical Equipment House Company (4014.SR) reported revenue of $0.88B for 2025, down 0.1% year-over-year.
4014.SR revenue4014.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15